Blockade of visfatin induction by oleanolic acid via disturbing IL-6-TRAF6-NF-κB signaling of adipocytes

Experimental Biology and Medicine

Volumn 239, Issue 3, 2014, Pages 284-292

  Kim, Hyun Sung ^a   Han, Seon Young ^a   Sung, Hye Young ^a   Park, Sin Hye ^a   Kang, Min Kyung ^a   Han, Seoung Jun ^b   Kang, Young Hee ^a  

^a Hallym University   (South Korea)

^b Seorim Bio   (South Korea)

Author keywords

Adipocyte differentiation; nuclear factor B; obesity; oleanolic acid; TRAF6; visfatin

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OLEANOLIC ACID; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ADIPOCYTE DIFFERENTIATION; NUCLEAR FACTOR-ΚB; OBESITY; OLEANOLIC ACID; TRAF6; VISFATIN;

3T3 CELLS; ACTIVE TRANSPORT, CELL NUCLEUS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHEMOKINE CXCL2; GENE EXPRESSION; I-KAPPA B KINASE; INTERLEUKIN-6; MICE; NF-KAPPA B; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OLEANOLIC ACID; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84896046211     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213514511     Document Type: Article

References (25)

1. Dixit VD.Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span.J Leukoc Biol. 2008;84:882-92.
2. Lehr S,Hartwig S,Sell H.Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders.Proteomics Clin Appl. 2012;6:91-101.
3. Scarpellini E,Tack J.Obesity and metabolic syndrome: an inflammatory condition.Dig Dis. 2012;30:148-53.
4. Pilz S,Mangge H,Obermayer-Pietsch B,März W.Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions.J Endocrinol Invest. 2007;30:138-44.
5. Stofkova A.Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity.Endocr Regul. 2010;44:25-36.
6. Moschen AR,Gerner RR,Tilg H.Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders.Curr Pharm Des. 2010;16:1913-20.
7. Garten A,Petzold S,Schuster S,Körner A,Kratzsch J,Kiess W.Nampt and its potential role in inflammation and type 2 diabetes.Handb Exp Pharmacol. 2011;203:147-64.
8. Romacho T,Azcutia V,Vázquez-Bella M,Matesanz N,Cercas E,Nevado J,Carraro R,Rodríguez-Mañas L,Sánchez-Ferrer CF,Peiró C.Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity.Diabetologia. 2009;52:2455-63.
9. Sultana N,Ata A.Oleanolic acid and related derivatives as medicinally important compounds.J Enzyme Inhib Med Chem. 2008;23:739-56.
10. de Melo CL,Queiroz MG,Fonseca SG,Bizerra AM,Lemos TL,Melo TS,Santos FA,Rao VS.Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet.Chem Biol Interact. 2010;185:59-65.
11. Sung HY,Kang SW,Kim JL,Li J,Lee ES,Gong JH,Han SJ,Kang YH.Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes.Nutr Res. 2010;30:831-39.
12. Kim HS,Sung HY,Kang YH.Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes.Nutr Res. 2013;33:144-53.
13. Kim MS,Lee MS,Kwon DY.Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals.Ann NY Acad Sci. 2011;1229:140-6.
14. Kim OY,Lee SM,Do H,Moon J,Lee KH,Cha YJ,Shin MJ.Influence of quercetin-rich onion peel extracts on adipokine expression in the visceral adipose tissue of rats.Phytother Res. 2012;26:432-7.
15. Derdemezis CS,Kiortsis DN,Tsimihodimos V,Petraki MP,Vezyraki P,Elisaf MS,Tselepis AD.Effect of plant polyphenols on adipokine secretion from human SGBS adipocytes.Biochem Res Int. 2011;2011:285618-285618.
16. Makino-Wakagi Y,Yoshimura Y,Uzawa Y,Zaima N,Moriyama T,Kawamura Y.Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes.Biochem Biophys Res Commun. 2012;417:880-5.
17. Kim SR,Park HJ,Bae YH,Ahn SC,Wee HJ,Yun I,Jang HO,Bae MK,Bae SK.Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion.Endocrinology. 2012;153:554-63.
18. Zhang XH,Huang B,Choi SK,Seo JS.Anti-obesity effect of resveratrol-amplified grape skin extracts on 3T3-L1 adipocytes differentiation.Nutr Res Prac. 2012;6:286-93.
19. Park SH,Park JHY,Kang JS,Kang YH.Involvement of transcription factors in plasma HDL protection against TNF-α-induced vascular cell adhesion molecule-1 expression.Int J Biochem Cell Biol. 2003;35:168-82.
20. Luk T,Malam Z,Marshall JC.Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.J Leukoc Biol. 2008;83:804-16.
21. Wiest R,Moleda L,Farkas S,Scherer M,Kopp A,Wönckhaus U,Büchler C,Schölmerich J,Schäffler A.Splanchnic concentrations and postprandial release of visceral adipokines.Metabolism. 2010;59:664-70.
22. Olszanecka-Glinianowicz M,Kocełak P,Nylec M,Chudek J,Zahorska-Markiewicz B.Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome.Arch Med Sci. 2012;8:214-8.
23. Chang YH,Chang DM,Lin KC,Shin SJ,Lee YJ.Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review.Diabetes Metab Res Rev. 2011;27:515-27.
24. Dahl TB,Yndestad A,Skjelland M,Øie E,Dahl A,Michelsen A,Damås JK,Tunheim SH,Ueland T,Smith C,Bendz B,Tonstad S,Gullestad L,Frøland SS,Krohg-Sørensen K,Russell D,Aukrust P,Halvorsen B.Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.Circulation. 2007;115:972-80.
25. Shehzad A,Ha T,Subhan F,Lee YS.New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases.Eur J Nutr. 2011;50:151-61.